It has been a banner year so far for Altimmune Inc. (ALT), whose share price has grown a whopping 990 percent year-to-date, thanks to the Company's pipeline progress, including its foray into COVID-19 drug and vaccine development space.
from RTT - Biotech https://ift.tt/2Cmp3dG
via IFTTT
No comments:
Post a Comment